Juventas Therapeutics
Focused on cell therapy
About the company
Cell therapy company with pipeline in hematologic malignancies, solid tumors, and auto-immune diseases. Lead asset is the first approved Chinese developed CD19-directed CAR-T
Focused on cell therapy
Cell therapy company with pipeline in hematologic malignancies, solid tumors, and auto-immune diseases. Lead asset is the first approved Chinese developed CD19-directed CAR-T